Cargando…

Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study

BACKGROUND: Regarding the increasing adoption of oblique lateral interbody fusion (OLIF) for treating degenerative lumbar disorders, we aimed to evaluate whether OLIF, one of the options for anterolateral approach lumbar interbody fusion, demonstrate clinical superiority over anterior lumbar interbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Kuan-Kai, Tseng, Wei-Cheng, Wu, Yun-Che, Chen, Kun-Hui, Pan, Chien-Chou, Lu, Wen-Xian, Shih, Cheng-Min, Lee, Cheng-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979469/
https://www.ncbi.nlm.nih.gov/pubmed/36864438
http://dx.doi.org/10.1186/s13018-023-03652-5
_version_ 1784899732744699904
author Tung, Kuan-Kai
Tseng, Wei-Cheng
Wu, Yun-Che
Chen, Kun-Hui
Pan, Chien-Chou
Lu, Wen-Xian
Shih, Cheng-Min
Lee, Cheng-Hung
author_facet Tung, Kuan-Kai
Tseng, Wei-Cheng
Wu, Yun-Che
Chen, Kun-Hui
Pan, Chien-Chou
Lu, Wen-Xian
Shih, Cheng-Min
Lee, Cheng-Hung
author_sort Tung, Kuan-Kai
collection PubMed
description BACKGROUND: Regarding the increasing adoption of oblique lateral interbody fusion (OLIF) for treating degenerative lumbar disorders, we aimed to evaluate whether OLIF, one of the options for anterolateral approach lumbar interbody fusion, demonstrate clinical superiority over anterior lumbar interbody fusion (ALIF) or posterior approach, represented by transforaminal lumbar interbody fusion (TLIF). METHODS: Patients who received ALIF, OLIF, and TLIF for symptomatic degenerative lumbar disorders during the period 2017–2019 were identified. Radiographic, perioperative, and clinical outcomes were recorded and compared during 2-year follow-up. RESULTS: A total of 348 patients with 501 correction levels were enrolled in the study. Fundamental sagittal alignment profiles were substantially improved at 2-year follow-up, particularly in the anterolateral approach (A/OLIF) group. The Oswestry disability index (ODI) and EuroQol-5 dimension (EQ-5D) in the ALIF group were superior when compared to the OLIF and TLIF group 2-year following surgery. However, comparisons of VAS-Total, VAS-Back, and VAS-Leg revealed no statistically significance across all approaches. TLIF demonstrated highest subsidence rate of 16%, while OLIF had least blood loss and was suitable for high body mass index patients. CONCLUSIONS: Regarding treatment for degenerative lumbar disorders, ALIF of anterolateral approach demonstrated superb alignment correction and clinical outcome. Comparing to TLIF, OLIF possessed advantage in reducing blood loss, restoring sagittal profiles and the accessibility at all lumbar level while simultaneously achieving comparable clinical improvement. Patient selection in accordance with baseline conditions, and surgeon preference both remain crucial issues circumventing surgical approach strategy.
format Online
Article
Text
id pubmed-9979469
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99794692023-03-03 Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study Tung, Kuan-Kai Tseng, Wei-Cheng Wu, Yun-Che Chen, Kun-Hui Pan, Chien-Chou Lu, Wen-Xian Shih, Cheng-Min Lee, Cheng-Hung J Orthop Surg Res Research Article BACKGROUND: Regarding the increasing adoption of oblique lateral interbody fusion (OLIF) for treating degenerative lumbar disorders, we aimed to evaluate whether OLIF, one of the options for anterolateral approach lumbar interbody fusion, demonstrate clinical superiority over anterior lumbar interbody fusion (ALIF) or posterior approach, represented by transforaminal lumbar interbody fusion (TLIF). METHODS: Patients who received ALIF, OLIF, and TLIF for symptomatic degenerative lumbar disorders during the period 2017–2019 were identified. Radiographic, perioperative, and clinical outcomes were recorded and compared during 2-year follow-up. RESULTS: A total of 348 patients with 501 correction levels were enrolled in the study. Fundamental sagittal alignment profiles were substantially improved at 2-year follow-up, particularly in the anterolateral approach (A/OLIF) group. The Oswestry disability index (ODI) and EuroQol-5 dimension (EQ-5D) in the ALIF group were superior when compared to the OLIF and TLIF group 2-year following surgery. However, comparisons of VAS-Total, VAS-Back, and VAS-Leg revealed no statistically significance across all approaches. TLIF demonstrated highest subsidence rate of 16%, while OLIF had least blood loss and was suitable for high body mass index patients. CONCLUSIONS: Regarding treatment for degenerative lumbar disorders, ALIF of anterolateral approach demonstrated superb alignment correction and clinical outcome. Comparing to TLIF, OLIF possessed advantage in reducing blood loss, restoring sagittal profiles and the accessibility at all lumbar level while simultaneously achieving comparable clinical improvement. Patient selection in accordance with baseline conditions, and surgeon preference both remain crucial issues circumventing surgical approach strategy. BioMed Central 2023-03-02 /pmc/articles/PMC9979469/ /pubmed/36864438 http://dx.doi.org/10.1186/s13018-023-03652-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tung, Kuan-Kai
Tseng, Wei-Cheng
Wu, Yun-Che
Chen, Kun-Hui
Pan, Chien-Chou
Lu, Wen-Xian
Shih, Cheng-Min
Lee, Cheng-Hung
Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title_full Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title_fullStr Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title_full_unstemmed Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title_short Comparison of radiographic and clinical outcomes between ALIF, OLIF, and TLIF over 2-year follow-up: a comparative study
title_sort comparison of radiographic and clinical outcomes between alif, olif, and tlif over 2-year follow-up: a comparative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979469/
https://www.ncbi.nlm.nih.gov/pubmed/36864438
http://dx.doi.org/10.1186/s13018-023-03652-5
work_keys_str_mv AT tungkuankai comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT tsengweicheng comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT wuyunche comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT chenkunhui comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT panchienchou comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT luwenxian comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT shihchengmin comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy
AT leechenghung comparisonofradiographicandclinicaloutcomesbetweenalifolifandtlifover2yearfollowupacomparativestudy